Seasonal Patterns in Tetracycline-Associated Hyperpigmentation Among Patients With Acne Vulgaris

November 2023 | Volume 22 | Issue 11 | e9 | Copyright © November 2023


Published online October 20, 2023

Katherine Young BS MEnga, Angel D. Pagan BSb,c, Jaewon Yoon BAa, Ethiopia Getachew BSa, Bonnie Leung BScc, Nga Nguyen BAc, Yevgeniy R. Semenov MD MAc, Arash Mostaghimi MD MPA MPHd*, Nicholas Theodosakis MD PhDc*

aHarvard Medical School, Boston, MA 
bPonce Health Sciences University School of Medicine, Ponce, Puerto Rico 
cMassachusetts General Hospital, Department of Dermatology, Boston, MA 
dBrigham and Women’s Hospital, Department of Dermatology, Boston, MA

*Denotes equal contribution



"dark spots" in the United States (US), United Kingdom (UK), and Australia from January 2004 to June 2022. We used the chi-squared test to examine seasonal effects and Spearman’s rank test to correlate with search volume. 

Of 2,830 acne patients, 16.6% of patients were male and the mean age was 29.9±12.6 years. Seasonal differences in new hyperpigmentation diagnoses were identified among patients prescribed doxycycline (P=0.016), but not among those prescribed minocycline (P=0.885). More new diagnoses occurred in spring compared to winter (P=0.006) among doxycycline users, with most diagnoses occurring in April. Among patients who never received a TCN, hyperpigmentation diagnoses were also seasonally distributed (P<0.001), peaking in May. In this reference population, there were more diagnoses in spring (P=0.003) and summer (P=0.003) than in winter (Figure 1). In the US and UK, there was greater search volume in spring and summer compared to fall and winter (P<0.001). This trend was mirrored in Australia (P<0.001, Figure 2). Doxycycline-associated hyperpigmentation and hyperpigmentation-related searches in the US were correlated (P=0.67, P<0.05).